{"id":"https://openalex.org/W3207213207","doi":"https://doi.org/10.2147/dddt.s332026","title":"The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study","display_name":"The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study","publication_year":2021,"publication_date":"2021-10-01","ids":{"openalex":"https://openalex.org/W3207213207","doi":"https://doi.org/10.2147/dddt.s332026","mag":"3207213207","pmid":"https://pubmed.ncbi.nlm.nih.gov/34703212","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8526518"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s332026","doi":"https://doi.org/10.2147/dddt.s332026","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s332026","pdf_url":"https://www.dovepress.com/getfile.php?fileID=74980","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=74980","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046162184","display_name":"David P. Walling","orcid":"https://orcid.org/0000-0001-8638-2086","observed_orcids":["https://orcid.org/0000-0001-8638-2086"]},"institutions":[{"id":"https://openalex.org/I4210129757","display_name":"Collaborative Neuroscience Network","ror":"https://ror.org/034a8v770","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210129757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P Walling","raw_affiliation_strings":["Collaborative Neuroscience Network, LLC Garden Grove, Garden Grove, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Collaborative Neuroscience Network, LLC Garden Grove, Garden Grove, CA, USA","institution_ids":["https://openalex.org/I4210129757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111638808","display_name":"Howard A Hassman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110205","display_name":"Hassman Research Institute","ror":"https://ror.org/01zmatx12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110205"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard A Hassman","raw_affiliation_strings":["Hassman Research Institute, Berlin, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hassman Research Institute, Berlin, NJ, USA","institution_ids":["https://openalex.org/I4210110205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012684643","display_name":"Lourdes Anta","orcid":"https://orcid.org/0000-0001-5981-1850","observed_orcids":["https://orcid.org/0000-0001-5981-1850"]},"institutions":[{"id":"https://openalex.org/I4210089961","display_name":"Laboratorios Farmace\u00faticos Rovi (Spain)","ror":"https://ror.org/00fc1yz57","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210089961"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lourdes Anta","raw_affiliation_strings":["Medical Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0001-5981-1850","affiliations":[{"raw_affiliation_string":"Medical Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain","institution_ids":["https://openalex.org/I4210089961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055728132","display_name":"Lourdes OCHOA D.","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089961","display_name":"Laboratorios Farmace\u00faticos Rovi (Spain)","ror":"https://ror.org/00fc1yz57","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210089961"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lourdes Ochoa","raw_affiliation_strings":["R&D Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain","institution_ids":["https://openalex.org/I4210089961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000848927","display_name":"Ignacio Ayani","orcid":"https://orcid.org/0000-0001-7654-3763","observed_orcids":["https://orcid.org/0000-0001-7654-3763"]},"institutions":[{"id":"https://openalex.org/I4210089961","display_name":"Laboratorios Farmace\u00faticos Rovi (Spain)","ror":"https://ror.org/00fc1yz57","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210089961"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ignacio Ayani","raw_affiliation_strings":["Medical Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain","institution_ids":["https://openalex.org/I4210089961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014324002","display_name":"Javier Mart\u00ednez","orcid":"https://orcid.org/0000-0001-6314-4480","observed_orcids":["https://orcid.org/0000-0001-6314-4480"]},"institutions":[{"id":"https://openalex.org/I4210089961","display_name":"Laboratorios Farmace\u00faticos Rovi (Spain)","ror":"https://ror.org/00fc1yz57","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210089961"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Javier Mart\u00ednez","raw_affiliation_strings":["Medical Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain","institution_ids":["https://openalex.org/I4210089961"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067167326","display_name":"Ib\u00f3n Gutierro","orcid":"https://orcid.org/0000-0002-7533-9194","observed_orcids":["https://orcid.org/0000-0002-7533-9194"]},"institutions":[{"id":"https://openalex.org/I4210089961","display_name":"Laboratorios Farmace\u00faticos Rovi (Spain)","ror":"https://ror.org/00fc1yz57","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210089961"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ibon Gutierro","raw_affiliation_strings":["R&D Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0002-7533-9194","affiliations":[{"raw_affiliation_string":"R&D Department, Laboratorios Farmac\u00e9uticos ROVI, S.A., Madrid, Spain","institution_ids":["https://openalex.org/I4210089961"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5014324002"],"corresponding_institution_ids":["https://openalex.org/I4210089961"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":1.3937,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.78131739,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"Volume 15","issue":null,"first_page":"4371","last_page":"4382"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7490000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7490000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0502999983727932,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.028200000524520874,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.8100000023841858},{"id":"https://openalex.org/keywords/intramuscular-administration","display_name":"intramuscular administration","score":0.7680000066757202},{"id":"https://openalex.org/keywords/steady-state-pharmacokinetics","display_name":"steady-state pharmacokinetics","score":0.875},{"id":"https://openalex.org/keywords/paliperidone","display_name":"paliperidone","score":0.9120000004768372},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6200000047683716},{"id":"https://openalex.org/keywords/antipsychotic-drug-delivery","display_name":"antipsychotic drug delivery","score":0.5839999914169312},{"id":"https://openalex.org/keywords/implantable-drug-delivery-systems","display_name":"implantable drug delivery","score":0.41600000858306885},{"id":"https://openalex.org/keywords/plasma-concentration-fluctuation","display_name":"plasma concentration fluctuation","score":0.546999990940094},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.7310000061988831},{"id":"https://openalex.org/keywords/once-monthly-dosing","display_name":"once-monthly dosing","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.9721819162368774},{"id":"https://openalex.org/C2908997079","wikidata":"https://www.wikidata.org/wiki/Q27157250","display_name":"Paliperidone Palmitate","level":4,"score":0.5784844160079956},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5700328350067139},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.5664443373680115},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5224222540855408},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4931632876396179},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4761883318424225},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4162510633468628},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40255749225616455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39915114641189575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3587285578250885},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32215312123298645},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.21546047925949097},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.1803845465183258},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.16284000873565674},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.15767860412597656},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004343","descriptor_name":"Drug Implants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2147/dddt.s332026","doi":"https://doi.org/10.2147/dddt.s332026","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s332026","pdf_url":"https://www.dovepress.com/getfile.php?fileID=74980","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7431023","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC8526518","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:34703212","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34703212","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:8526518","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8526518/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Des Devel Ther","raw_type":"Text"},{"id":"pmh:oai:dovepress.com/69770","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/the-steady-state-comparative-bioavailability-of-intramuscular-risperid-peer-reviewed-fulltext-article-DDDT","pdf_url":"https://www.dovepress.com/the-steady-state-comparative-bioavailability-of-intramuscular-risperid-peer-reviewed-fulltext-article-DDDT","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:a256d4300d484f2c90cfa6b6c8041253","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a256d4300d484f2c90cfa6b6c8041253","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol Volume 15, Pp 4371-4382 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.2147/dddt.s332026","doi":"https://doi.org/10.2147/dddt.s332026","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s332026","pdf_url":"https://www.dovepress.com/getfile.php?fileID=74980","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321043","display_name":"Centro para el Desarrollo Tecnol\u00f3gico Industrial","ror":"https://ror.org/0124x7055"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3207213207.pdf","grobid_xml":"https://content.openalex.org/works/W3207213207.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1980466924","https://openalex.org/W1992457778","https://openalex.org/W1999689270","https://openalex.org/W2009652756","https://openalex.org/W2037386295","https://openalex.org/W2061211518","https://openalex.org/W2089315440","https://openalex.org/W2096271865","https://openalex.org/W2126097234","https://openalex.org/W2138959943","https://openalex.org/W2162814669","https://openalex.org/W2165379748","https://openalex.org/W2174934002","https://openalex.org/W2219812044","https://openalex.org/W2464467657","https://openalex.org/W2527103551","https://openalex.org/W2767770516","https://openalex.org/W2957311488","https://openalex.org/W3083432627","https://openalex.org/W3124121244"],"related_works":["https://openalex.org/W1972852190","https://openalex.org/W2352123895","https://openalex.org/W2029950512","https://openalex.org/W2464467657","https://openalex.org/W4403406332","https://openalex.org/W2767770516","https://openalex.org/W2791629423","https://openalex.org/W4407191421","https://openalex.org/W4408038509","https://openalex.org/W7172044723"],"abstract_inverted_index":{"Introduction:":[0],"This":[1],"open-label,":[2],"one-sequence":[3],"study":[4],"evaluated":[5],"the":[6,86,92,97,157,179,182,243,261,264,272,285,308,315],"steady-state":[7,59,98,134,192,273,305],"comparative":[8,326],"bioavailability":[9],"of":[10,32,53,77,120,144,257,263,307],"risperidone":[11,20,26,37,54,69,104,114,116,145,149,160,225,232,258,276,288,291,319],"in":[12,21,85,140,242,297],"situ":[13],"microimplants":[14],"(ISM":[15],"\u00ae":[16],")":[17],"and":[18,68,89,126,138,167,196,216,228,239,313],"oral":[19,25,30,113,159,224,251,275,287,318],"patients":[22,299],"stabilized":[23,249],"on":[24],"treatment.":[27,277],"Methods:":[28],"Repeat":[29],"administration":[31,151],"once":[33,222,229],"daily":[34,223],"4":[35,44,226],"mg":[36,227,235],"for":[38,64,96,103,112,317,335],"7":[39],"days":[40],"was":[41,72],"followed":[42],"by":[43],"monthly":[45,230],"(once":[46],"every":[47],"four":[48],"weeks)":[49],"intramuscular":[50],"(IM)":[51],"doses":[52],"ISM":[55,117,150,233,259,292],"100":[56,234],"mg.":[57],"Mean":[58],"concentration":[60,132,190,199],"versus":[61,100,115],"time":[62,101,302],"profiles":[63,102],"risperidone,":[65,67,332],"9-OH":[66],"active":[70,105,146,309],"moiety":[71,106,147,310],"characterized.":[73],"Results:":[74],"A":[75],"total":[76],"104":[78],"subjects":[79,245],"were":[80,83,173,202,236],"enrolled,":[81],"81":[82],"included":[84],"safety":[87],"population":[88],"58":[90],"completed":[91],"study.":[93],"Intersubject":[94],"variability":[95,110],"concentrations":[99,142],"presented":[107],"a":[108],"greater":[109],"range":[111],"(%":[118],"coefficient":[119],"variation":[121],"[CV]":[122],"range:":[123],"40\u2013":[124],"65%":[125],"38\u2013":[127],"52%,":[128],"respectively).":[129,220],"Minimum":[130],"plasma":[131,141,189,198],"at":[133,191,271],"(C":[135,193,200],"min,":[136],"ss)":[137,195],"fluctuation":[139],"(Fluc)":[143],"after":[148,274,281],"met":[152],"bioequivalence":[153],"criteria":[154],"compared":[155],"to":[156,268,290],"reference":[158],"(geometric":[161],"mean":[162],"ratio":[163],"[GMR]":[164],"=":[165,209],"1.09":[166],"0.96,":[168],"respectively;":[169],"both":[170],"90%":[171],"CIs":[172],"within":[174],"0.80\u2013":[175],"1.25).":[176],"Area":[177],"under":[178],"curve":[180],"during":[181],"dosing":[183],"interval":[184],"(AUC":[185],"tau)":[186],",":[187],"maximum":[188],"max,":[194],"average":[197],"ave)":[201],"only":[203],"slightly":[204],"higher":[205],"(GMR":[206],"[90%":[207],"CI]":[208],"1.25":[210,217],"[1.16\u2013":[211,218],"1.34],":[212,219],"1.17":[213],"[1.08\u2013":[214],"1.27],":[215],"Overall,":[221],"IM":[231],"generally":[237],"safe":[238],"well":[240],"tolerated":[241],"participating":[244],"with":[246,250,300],"schizophrenia":[247,298,333],"previously":[248],"risperidone.":[252],"Conclusion:":[253],"The":[254],"rapid":[255],"release":[256],"allows":[260],"achievement":[262],"desired":[265],"levels":[266,306],"similar":[267],"those":[269],"observed":[270],"Therefore,":[278],"direct":[279],"switch":[280],"24":[282],"hours":[283],"from":[284],"last":[286],"dose":[289],"treatment":[293,312],"can":[294],"be":[295],"done":[296],"no":[301],"lag,":[303],"maintaining":[304],"throughout":[311],"without":[314],"need":[316],"supplementation":[320],"or":[321],"loading":[322],"doses.":[323],"Keywords:":[324],"bioequivalence,":[325],"bioavailability,":[327],"long-acting":[328],"injectables,":[329],"LAIs,":[330],"pharmacokinetic,":[331],"Corrigendum":[334],"this":[336],"paper":[337],"has":[338],"been":[339],"published":[340]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-10-25T00:00:00"}